摘要 |
The present invention relates to pharmaceutical or nutritional or food compostion for feeding infants, which is more similar to human milk in a powder or fluid form, having an effect of addresseing the shortcomings of the presently known infant formulas by the inclusion of a phospholipid supplement which contains phosphatidylserine or salts thereof as one of the effective ingredients and comprising at least 1% (w/w) phosphatidyserine out of the total phospholipid content of the composition, wherein the phosphatidylserine has a structural fatty acid chain derived from at least one raw material lecithin selected from the group consisting of soy bean lecithin, rapeseed lecithin, or egg yolk lecithin, and which is produced by reaction with phospholipase-D. |